3-quinuclidinyl-4-iodobenzilate has been researched along with iofetamine in 1 studies
Studies (3-quinuclidinyl-4-iodobenzilate) | Trials (3-quinuclidinyl-4-iodobenzilate) | Recent Studies (post-2010) (3-quinuclidinyl-4-iodobenzilate) | Studies (iofetamine) | Trials (iofetamine) | Recent Studies (post-2010) (iofetamine) |
---|---|---|---|---|---|
37 | 4 | 0 | 920 | 52 | 87 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albert, M; Eckelman, WC; Gibson, RE; Hill, TC; Holman, BL; Reba, RC | 1 |
1 other study(ies) available for 3-quinuclidinyl-4-iodobenzilate and iofetamine
Article | Year |
---|---|
Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomography.
Topics: Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Humans; Iodine Radioisotopes; Iofetamine; Male; Middle Aged; Quinuclidines; Quinuclidinyl Benzilate; Radioligand Assay; Receptors, Muscarinic; Tomography, Emission-Computed | 1985 |